|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.26 USD | +1.80% |
|
-2.98% | +61.45% |
| 06-30 | Nektar Therapeutics(NasdaqCM:NKTR) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 2000 Index | CI |
| Market Cap | 2.31B 2.02B 1.86B 1.71B 3.23B 222B 3.3B 22.23B 8.74B 109B 8.66B 8.47B 374B | P/E 2026 * |
-7.61x | P/E 2027 * | -6.19x |
|---|---|---|---|---|---|
| Enterprise Value | 2.31B 2.02B 1.86B 1.71B 3.23B 222B 3.3B 22.23B 8.74B 109B 8.66B 8.47B 374B | EV / Sales 2026 * |
56x | EV / Sales 2027 * | 62.5x |
| Free-Float |
99.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nektar Therapeutics
| 1 day | +1.80% | ||
| 1 week | -2.98% | ||
| Current month | -2.22% | ||
| 1 month | +12.05% | ||
| 3 months | -19.56% | ||
| 6 months | +81.16% | ||
| Current year | +61.45% |
| 1 week | 64.46 |  | 69.99 |
| 1 month | 61.29 | | 77.23 |
| Current year | 33.4 | | 109 |
| 1 year | 21.02 | | 109 |
| 3 years | 6.19 | | 109 |
| 5 years | 6.19 | | 290.55 |
| 10 years | 6.19 | | 1,670.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 73 | 01/01/2007 |
Linda Rubinstein
DFI | Director of Finance/CFO | 60 | 15/05/2026 |
| Chief Tech/Sci/R&D Officer | 52 | 01/07/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Roy Whitfield
BRD | Director/Board Member | 72 | 01/08/2000 |
Robert Chess
CHM | Chairman | 69 | 01/05/1992 |
Howard Robin
BRD | Director/Board Member | 73 | 01/02/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06/26 | Sell | Chief Technology Officer | -5,681 | 0.0168% | ||
| 17/06/26 | Sell | Chief Executive Officer | -10,000 | 0.0296% | ||
| 15/06/26 | Sell | Chief Technology Officer | -5,538 | 0.0164% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | -2.98% | +155.94% | +723.65% | 2.31B | |
| -7.17% | -4.39% | +45.51% | +79.00% | 52.1B | |
| +0.24% | -1.54% | +53.22% | +71.85% | 53.83B | |
| +0.80% | -6.31% | +3.98% | +423.29% | 23.48B | |
| -0.09% | -0.01% | -17.62% | -14.67% | 23.13B | |
| -5.95% | -2.58% | +30.67% | -9.58% | 19.36B | |
| -1.14% | +0.03% | +31.57% | -30.42% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +306.37% | 15.2B | |
| -6.91% | -5.83% | +26.53% | +636.97% | 14.83B | |
| +0.43% | -1.03% | +24.63% | +191.40% | 14.06B | |
| Average | -2.32% | -2.66% | +52.29% | +237.78% | 23.59B | |
| Weighted average by Cap. | -2.76% | -2.36% | +41.25% | +149.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.22M 36.02M 33.24M 30.64M 57.75M 3.97B 59.03M 397M 156M 1.94B 155M 151M 6.69B | 36.91M 32.25M 29.76M 27.43M 51.71M 3.55B 52.85M 356M 140M 1.74B 139M 136M 5.99B |
| Net income | -249M -217M -200M -185M -348M -23.93B -356M -2.4B -942M -11.72B -933M -913M -40.35B | -355M -310M -286M -264M -497M -34.2B -509M -3.42B -1.35B -16.75B -1.33B -1.3B -57.65B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $68.26 | +1.80% | 538,398 |
| 16/07/26 | $67.05 | -1.83% | 746,227 |
| 15/07/26 | $68.30 | +1.68% | 543,479 |
| 14/07/26 | $67.17 | -1.68% | 814,761 |
| 13/07/26 | $68.32 | -2.90% | 666,895 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NKTR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
